The use of the Presage ST2 Assay to evaluate the prognosis of patients diagnosed with chronic heart failure is considered investigational.
The use of the Presage ST2 Assay to guide management (eg, pharmacologic, device-based, exercise) of patients diagnosed with chronic heart failure is considered investigational.
The use of the Presage ST2 Assay in the post cardiac transplantation period, including but not limited to predicting prognosis and predicting acute cellular rejection, is considered investigational.
The use of the myTAIHEART assay in the post cardiac transplantation period, including but not limited to predicting prognosis and predicting acute cellular rejection, is considered investigational.
